{
  "issues": [
    "Renal tool flagged elevated creatinine (1.7 mg/dL) and a BUN/Cr ratio of 20, suggesting possible prerenal azotemia in the context of hypotension (SBP 82 mmHg, MAP 59 mmHg).",
    "Renal tool reported missing BMI and lack of lab timestamps, limiting accurate assessment of current renal risk and contrast dosing.",
    "Agent 2 recommends CT pulmonary angiography despite the patient’s hypotension and moderate CKD, which increases the risk of contrast‑induced nephropathy and may worsen renal perfusion.",
    "Hydration recommendation does not account for the patient's low blood pressure; aggressive IV fluids could precipitate volume overload or exacerbate hypotension.",
    "No alternative imaging modality (e.g., ventilation‑perfusion scan) was considered despite the renal and hemodynamic concerns."
  ],
  "recommendations": [
    "Obtain a repeat serum creatinine and BUN with exact timestamps to confirm current renal function before proceeding with contrast administration.",
    "Calculate the patient’s body mass index (BMI) and use weight‑based contrast dosing per ACR guidelines.",
    "If CT pulmonary angiography remains the preferred study, implement a renal protection protocol: isotonic saline at 1 mL/kg/h (or reduced rate if hypotensive) started 12 h before and continued 6–12 h after contrast, with close monitoring of fluid balance and blood pressure.",
    "Consider an alternative imaging strategy (e.g., V/Q scan or bedside transthoracic echocardiography with agitated saline) if the risk of contrast‑induced nephropathy or hemodynamic instability is deemed high.",
    "Document informed consent that explicitly discusses the potential risk of contrast‑induced nephropathy given the patient’s CKD stage 3a and hypotension.",
    "Plan for post‑contrast renal monitoring: repeat creatinine at 24 h and 48 h post‑study, and adjust management based on trends.",
    "Update the imaging protocol note to include the patient’s hemodynamic status and the renal protection measures applied."
  ],
  "confidence": 0.61,
  "agent2_confidence": 0.65,
  "timestamp": "2025-08-26T10:04:21.008661Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-08-26T10:04:13.802451Z",
          "priority": "critical",
          "value": 59.0,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-08-26T10:04:13.802460Z",
          "priority": "critical",
          "value": 1.7,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-08-26T10:04:13.802464Z",
          "priority": "important",
          "value": 20.0,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-08-26T10:04:13.802472Z",
          "priority": "important",
          "value": 4.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-08-26T10:04:13.802503Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool flagged elevated creatinine (1.7 mg/dL) and a BUN/Cr ratio of 20, suggesting possible prerenal azotemia in the context of hypotension (SBP 82 mmHg, MAP 59 mmHg).\",\n    \"Renal tool reported missing BMI and lack of lab timestamps, limiting accurate assessment of current renal risk and contrast dosing.\",\n    \"Agent 2 recommends CT pulmonary angiography despite the patient’s hypotension and moderate CKD, which increases the risk of contrast‑induced nephropathy and may worsen renal perfusion.\",\n    \"Hydration recommendation does not account for the patient's low blood pressure; aggressive IV fluids could precipitate volume overload or exacerbate hypotension.\",\n    \"No alternative imaging modality (e.g., ventilation‑perfusion scan) was considered despite the renal and hemodynamic concerns.\"\n  ],\n  \"recommendations\": [\n    \"Obtain a repeat serum creatinine and BUN with exact timestamps to confirm current renal function before proceeding with contrast administration.\",\n    \"Calculate the patient’s body mass index (BMI) and use weight‑based contrast dosing per ACR guidelines.\",\n    \"If CT pulmonary angiography remains the preferred study, implement a renal protection protocol: isotonic saline at 1 mL/kg/h (or reduced rate if hypotensive) started 12 h before and continued 6–12 h after contrast, with close monitoring of fluid balance and blood pressure.\",\n    \"Consider an alternative imaging strategy (e.g., V/Q scan or bedside transthoracic echocardiography with agitated saline) if the risk of contrast‑induced nephropathy or hemodynamic instability is deemed high.\",\n    \"Document informed consent that explicitly discusses the potential risk of contrast‑induced nephropathy given the patient’s CKD stage 3a and hypotension.\",\n    \"Plan for post‑contrast renal monitoring: repeat creatinine at 24 h and 48 h post‑study, and adjust management based on trends.\",\n    \"Update the imaging protocol note to include the patient’s hemodynamic status and the renal protection measures applied.\"\n  ],\n  \"confidence\": 0.71\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool flagged elevated creatinine (1.7 mg/dL) and a BUN/Cr ratio of 20, suggesting possible prerenal azotemia in the context of hypotension (SBP 82 mmHg, MAP 59 mmHg).",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '82'"
      },
      {
        "text": "Renal tool reported missing BMI and lack of lab timestamps, limiting accurate assessment of current renal risk and contrast dosing.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 recommends CT pulmonary angiography despite the patient’s hypotension and moderate CKD, which increases the risk of contrast‑induced nephropathy and may worsen renal perfusion.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Hydration recommendation does not account for the patient's low blood pressure; aggressive IV fluids could precipitate volume overload or exacerbate hypotension.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "No alternative imaging modality (e.g., ventilation‑perfusion scan) was considered despite the renal and hemodynamic concerns.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain a repeat serum creatinine and BUN with exact timestamps to confirm current renal function before proceeding with contrast administration.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Calculate the patient’s body mass index (BMI) and use weight‑based contrast dosing per ACR guidelines.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "If CT pulmonary angiography remains the preferred study, implement a renal protection protocol: isotonic saline at 1 mL/kg/h (or reduced rate if hypotensive) started 12 h before and continued 6–12 h after contrast, with close monitoring of fluid balance and blood pressure.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Consider an alternative imaging strategy (e.g., V/Q scan or bedside transthoracic echocardiography with agitated saline) if the risk of contrast‑induced nephropathy or hemodynamic instability is deemed high.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document informed consent that explicitly discusses the potential risk of contrast‑induced nephropathy given the patient’s CKD stage 3a and hypotension.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Plan for post‑contrast renal monitoring: repeat creatinine at 24 h and 48 h post‑study, and adjust management based on trends.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '48'"
      },
      {
        "text": "Update the imaging protocol note to include the patient’s hemodynamic status and the renal protection measures applied.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "hemodynamic instability supported by MAP 59.0"
      }
    ],
    "counts": {
      "supported": 11,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 1,
      "contradicted": 0
    },
    "hallucination_score": 0.042,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.1
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 20028931.0,
        "hadm_id": 34567891.0,
        "stay_id": 44551234.0,
        "age": 72.0,
        "hospital_expire_flag": 0.0,
        "los_hospital_days": 4.2,
        "los_icu_days": 3.7,
        "creatinine_mg_dl": 1.7,
        "bun_mg_dl": 34.0,
        "glucose_mg_dl": 142.0,
        "hemoglobin_g_dl": 10.1,
        "hematocrit_pct": 30.5,
        "platelet_count": 210.0,
        "wbc_count": 12.3,
        "sodium_meq_l": 135.0,
        "potassium_mmol_l": 4.6,
        "chloride_meq_l": 100.0,
        "bicarbonate_meq_l": 21.0,
        "egfr_ckd_epi": 59.0,
        "ckd_stage": 3.0,
        "bun_creatinine_ratio": 20.0,
        "heart_rate_bpm": 95.0,
        "systolic_bp_mmhg": 82.0,
        "diastolic_bp_mmhg": 48.0,
        "map_mmhg": 59.0,
        "pulse_pressure_mmhg": 34.0,
        "temperature_f": 98.9,
        "spo2_pct": 94.0,
        "respiratory_rate": 22.0,
        "data_completeness_pct": 0.92
      },
      "raw_strings_sample": [
        "100.0",
        "bun/cr ratio suggests prerenal azotemia.",
        "21.0",
        "48",
        "white",
        "30.5",
        "3.7",
        "stage 3a (mild-to-moderate ckd)",
        "20.0",
        "right-sided chest pain with history of diabetes and hypertension"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool flagged elevated creatinine (1.7 mg/dL) and a BUN/Cr ratio of 20, suggesting possible prerenal azotemia in the context of hypotension (SBP 82 mmHg, MAP 59 mmHg).",
      "Renal tool reported missing BMI and lack of lab timestamps, limiting accurate assessment of current renal risk and contrast dosing.",
      "Agent 2 recommends CT pulmonary angiography despite the patient’s hypotension and moderate CKD, which increases the risk of contrast‑induced nephropathy and may worsen renal perfusion.",
      "Hydration recommendation does not account for the patient's low blood pressure; aggressive IV fluids could precipitate volume overload or exacerbate hypotension.",
      "No alternative imaging modality (e.g., ventilation‑perfusion scan) was considered despite the renal and hemodynamic concerns."
    ],
    "recommendations": [
      "Obtain a repeat serum creatinine and BUN with exact timestamps to confirm current renal function before proceeding with contrast administration.",
      "Calculate the patient’s body mass index (BMI) and use weight‑based contrast dosing per ACR guidelines.",
      "If CT pulmonary angiography remains the preferred study, implement a renal protection protocol: isotonic saline at 1 mL/kg/h (or reduced rate if hypotensive) started 12 h before and continued 6–12 h after contrast, with close monitoring of fluid balance and blood pressure.",
      "Consider an alternative imaging strategy (e.g., V/Q scan or bedside transthoracic echocardiography with agitated saline) if the risk of contrast‑induced nephropathy or hemodynamic instability is deemed high.",
      "Document informed consent that explicitly discusses the potential risk of contrast‑induced nephropathy given the patient’s CKD stage 3a and hypotension.",
      "Plan for post‑contrast renal monitoring: repeat creatinine at 24 h and 48 h post‑study, and adjust management based on trends.",
      "Update the imaging protocol note to include the patient’s hemodynamic status and the renal protection measures applied."
    ],
    "confidence": 0.61
  }
}